Symbol="MCRB"
AssetType="Common Stock"
Name="Seres Therapeutics Inc"
Description="Seres Therapeutics, Inc., a microbiome therapeutic platform company, is involved in the development of bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company is headquartered in Cambridge, Massachusetts."
CIK="1609809"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 SIDNEY STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="599856000"
EBITDA="-254848000"
PERatio="None"
PEGRatio="-0.11"
BookValue="-0.378"
DividendPerShare="0"
DividendYield="0"
EPS="-2.17"
RevenuePerShareTTM="0.044"
ProfitMargin="0"
OperatingMarginTTM="-51.11"
ReturnOnAssetsTTM="-0.553"
ReturnOnEquityTTM="-16.0"
RevenueTTM="5113000"
GrossProfitTTM="-165792000"
DilutedEPSTTM="-2.17"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.865"
AnalystTargetPrice="10.8"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="53.24"
PriceToBookRatio="11.41"
EVToRevenue="42.53"
EVToEBITDA="-2.793"
Beta="2.588"
num_52WeekHigh="9.49"
num_52WeekLow="3.912"
num_50DayMovingAverage="4.974"
num_200DayMovingAverage="5.71"
SharesOutstanding="127901000"
DividendDate="None"
ExDividendDate="None"
symbol="MCRB"
open="4.72"
high="4.81"
low="4.66"
price="4.81"
volume="1865368.00"
latest_trading_day="2023-07-31"
previous_close="4.69"
change="0.12"
change_percent="2.5586%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="69"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="31"
Volume_recent_avg="2850131"
Change_recent_avg="-0.02"
Delta_recent_avg="0.37"
Variance_recent_avg="0.18"
Change_ratio_recent_avg="-0.45"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="31"
Aroon_momentum_negative="69"
image_negative_thumbnail_id_1="1092"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0125.jpeg"
image_negative_thumbnail_id_2="126"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0050.jpeg"
image_neutral_thumbnail_id_1="544"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_neutral_thumbnail_id_2="574"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_positive_thumbnail_id_1="687"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0021.jpeg"
image_positive_thumbnail_id_2="964"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0126.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1203"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
